FLEURY ON NMFLEURY ON NMFLEURY ON NM

FLEURY ON NM

No trades
See on Supercharts
Market capitalization
‪8.04 B‬BRL
‪423.76 M‬BRL
‪6.47 B‬BRL
‪238.30 M‬
Beta (1Y)
0.89

About FLEURY ON NM

CEO
Jeane Mike Tsutsui
Headquarters
São Paulo
Employees (FY)
‪22.4 K‬
Founded
1926
ISIN
BRFLRYACNOR5
FIGI
BBG000PRR0C9
Fleury SA engaged in the provision of medical diagnostic services. Its brands include Fleury, Weinmann, Clínica, Felippe Mattoso a+, Labs a+, Diagnoson a+ and Serdil. It operates through the following segments: Diagnostic Medicine, Integrated Medicine, and Dental. The Diagnostic Medicine segment comprises of three business lines, such as patient service centers, hospital based diagnostics and diagnostic medicine solutions. It's also provides clinical analysis, including high-volume testing services, such as blood tests, pathology and highly complex testing and diagnostics, including diagnostic imaging and specialized medical diagnostics, such as cardiology, gastroenterology, gynecology, pregnancy and maternity. The Integrated Medicine segment offers executive health assessment, health promotion, chronic disease management, and drug administration services. The Dental segment gives tomography, intra and extra oral radiographs, orthodontic documentation, and dental arcade models. The company was founded by Gastao Fleury da Silveira in1926 and is headquartered in Sao Paulo, Brazil.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FLRY3F is 14.78 BRL — it has decreased by 0.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange FLEURY ON NM stocks are traded under the ticker FLRY3F.
FLEURY ON NM is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for FLEURY ON NM has a max estimate of 23.00 BRL and a min estimate of 16.00 BRL.
FLRY3F earnings for the last quarter are 0.32 BRL whereas the estimation was 0.28 BRL which accounts for 11.97% surprise. Estimated earnings for the next quarter are 0.16 BRL. See more details about FLEURY ON NM earnings.
FLEURY ON NM revenue for the last quarter amounts to ‪1.87 B‬ BRL despite the estimated figure of ‪1.88 B‬ BRL. In the next quarter revenue is expected to reach ‪1.75 B‬ BRL.
Yes, you can track FLEURY ON NM financials in yearly and quarterly reports right on TradingView.
Like other stocks, FLRY3F shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FLEURY ON NM stock right from TradingView charts — choose your broker and connect to your account.
FLRY3F reached its all-time high on Feb 5, 2020 with the price of 27.44 BRL, and its all-time low was 3.97 BRL and was reached on Oct 27, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has ‪22.40 K‬ employees. See our rating of the largest employees — is FLEURY ON NM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FLEURY ON NM EBITDA is ‪1.55 B‬ BRL, and current EBITDA margin is 24.27%. See more stats in FLEURY ON NM financial statements.